Suven Life Sciences Q4 Results
- BSE: 530239
- NSE: SUVEN
- ISIN: INE495B01038
- Sector: Biotechnology & Drugs
BSE
306.10
-2.40 (-0.78%)
-2.40 (-0.78%)Volume27.24 K
Updated: Mon 5 Oct, 2026 | 15:50:23
NSE
306.30-2.00 (-0.65%)
-2.00 (-0.65%)Volume3.03 L
Updated: Mon 5 Oct, 2026 | 15:50:28
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Suven Life Sciences Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 53.74 | 107.51 | -50.02% | 34.18 | 15.23% |
| Depreciation/ Amortization | 1.58 | 1.35 | 17.59% | 1.51 | 17.51% |
| Total Revenue | 1.52 | 2.81 | -45.88% | 2.39 | 3.62% |
| Operating Income | -52.22 | -,104.70 | -50.13% | -31.80 | 15.60% |
| Net Income | -45.60 | -,101.92 | -55.26% | -26.54 | 3.76% |
| Selling/ General/ Admin Expenses Total | 5.83 | 6.27 | -7.01% | 3.46 | -3.91% |
| Other Operating Expenses Total | 3.99 | 5.84 | -31.67% | 1.69 | 110.53% |
| Net Income Before Taxes | -45.60 | -,101.92 | -55.26% | -27.54 | 3.76% |
| Diluted Normalized EPS | -1.90 | -4.55 | -58.22% | -1.22 | -5.45% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.